Skip to main content

Table 3 The correlation between SAF and the number of T2DM complications

From: Skin autofluorescence and the complexity of complications in patients with type 2 diabetes mellitus: a cross-sectional study

 

0

1

2

3

4

P

Model 1

1 (Ref)

1.18 (0.71–1.68)

1.25 (1.13–1.77)

1.35 (1.20–1.90)

1.89 (1.45–2.24)

< 0.001***

Model 2

1 (Ref)

1.28 (1.09–1.74)

1.32 (1.17–1.82)

1.42 (1.15–2.17)

2.01 (1.75–2.85)

0.007**

Model 3

1 (Ref)

2.01 (0.61–3.70)

2.25 (1.53–2.79)

2.51 (1.60–2.72)

2.89 (1.45–2.26)

0.023*

Model 4

1 (Ref)

1.81 (0.62–2.12)

2.15 (0.81–3.09)

2.21 (1.72–2.93)

3.09 (1.89–3.57)

0.129

  1. Model 1: Not adjusted
  2. Model 2: AGE, Age, Sex, BMI
  3. Model 3: AGE, Age, Sex, BMI, FBG, HbA1c, C-pep, Smoking, Drinking, Hypertension
  4. Model 4: AGE, Age, Sex, BMI, FBG, HbA1c, C-pep, Smoking, Drinking, Hypertension, TGs, BUA, Cr, eGFR
  5. *P < 0.05, **P < 0.01, ***P < 0.001